Literature DB >> 7818569

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity.

J S Smolen1, F C Breedveld, G Eberl, I Jones, M Leeming, G L Wylie, J Kirkpatrick.   

Abstract

OBJECTIVE: To investigate the validity of the 28-joint count for assessment of joint involvement in patients with rheumatoid arthritis (RA).
METHODS: Joint involvement as determined by the 28- and the 66/68-joint count was compared using data from 735 prospectively studied RA patients.
RESULTS: The joints included in the 28-joint count were more commonly involved than other joints, and findings from the 28-joint count correlated highly with those from the 66/68-joint count in all analyses.
CONCLUSION: The 28-joint count is a reliable and valid measure for joint assessment. It is easier to perform than the 66/68-joint count, and it addresses the joints that are critically involved.

Entities:  

Mesh:

Year:  1995        PMID: 7818569     DOI: 10.1002/art.1780380106

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  62 in total

Review 1.  Clinical outcome measures in rheumatoid arthritis.

Authors:  P L van Riel; A M van Gestel
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

3.  Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis.

Authors:  Roma Pahwa; Uma Kumar; Nibhriti Das
Journal:  Mol Cell Biochem       Date:  2016-02-23       Impact factor: 3.396

4.  Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count.

Authors:  T Pincus; O G Segurado
Journal:  Ann Rheum Dis       Date:  2005-11-16       Impact factor: 19.103

5.  Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.

Authors:  D Anand; U Kumar; M Kanjilal; S Kaur; N Das
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

6.  The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.

Authors:  Piotr Adrian Klimiuk; Jacek Kita; Justyna Chwiecko; Stanislaw Sierakowski
Journal:  Clin Rheumatol       Date:  2008-07-29       Impact factor: 2.980

7.  Patients with active rheumatoid arthritis but only few tender and swollen joints: a subgroup with impaired short term outcome.

Authors:  C Fiehn; S Kessler; W Drexler; H M Lorenz
Journal:  Rheumatol Int       Date:  2008-11-08       Impact factor: 2.631

8.  Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials.

Authors:  Marian Kaldas; Puja P Khanna; Daniel E Furst; Philip J Clements; Weng Kee Wong; James R Seibold; Arnold E Postlethwaite; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2009-07-14       Impact factor: 7.580

9.  Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Romela Benitha; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

10.  Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model.

Authors:  Mi Ra Chang; Brent Lyda; Theodore M Kamenecka; Patrick R Griffin
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.